Effect of pilocarpine mouthwash on salivary flow

Pilocarpine is a cholinergic agonist that increases salivary flow and has been used to treat xerostomia. Oral intake is the most frequent route of administration. Adverse effects are dose-dependent and include sudoresis, facial blushing and increased urinary frequency. The objective of the present study was to evaluate the effects of topical pilocarpine solutions as mouthwashes on salivary flow and their adverse effects on healthy subjects. Forty volunteers received 10 ml 0.5, 1 and 2% pilocarpine solutions or 0.9% saline in a randomized, double-blind, placebo-controlled manner. Salivation was measured before and 45, 60 and 75 min after mouth rinsing for 1 min with 10 ml of saline or pilocarpine solutions. Vital signs were measured and ocular, gastrointestinal and cardiovascular symptoms, anxiety and flushing were estimated using visual analog scales. There was a dose-dependent increase in salivation. Salivation measured after 1 and 2% pilocarpine (1.4 ± 0.36 and 2.22 ± 0.42 g, respectively) was significantly (P<0.001) higher than before (0.70 ± 0.15 and 0.64 ± 0.1 g), with a plateau between 45 and 75 min. Cardiovascular, visual, gastrointestinal and behavioral symptoms and signs were not changed by topical pilocarpine. Mouth rinsing with pilocarpine solutions at concentrations of 1 to 2% induced a significant objective and subjective dose-dependent increase in salivary flow, similar to the results reported by others studying the effect of oral 5 mg pilocarpine. The present study revealed the efficacy of pilocarpine mouthwash solutions in increasing salivary flow in healthy volunteers, with no adverse effects. Additional studies on patients with xerostomia are needed.

Saved in:
Bibliographic Details
Main Authors: Bernardi,R., Perin,C., Becker,F.L., Ramos,G.Z., Gheno,G.Z., Lopes,L.R., Pires,M., Barros,H.M.T.
Format: Digital revista
Language:English
Published: Associação Brasileira de Divulgação Científica 2002
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2002000100015
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0100-879X2002000100015
record_format ojs
spelling oai:scielo:S0100-879X20020001000152001-12-07Effect of pilocarpine mouthwash on salivary flowBernardi,R.Perin,C.Becker,F.L.Ramos,G.Z.Gheno,G.Z.Lopes,L.R.Pires,M.Barros,H.M.T. Pilocarpine Mouth rinsing Mouthwash Xerostomia Salivation Pilocarpine is a cholinergic agonist that increases salivary flow and has been used to treat xerostomia. Oral intake is the most frequent route of administration. Adverse effects are dose-dependent and include sudoresis, facial blushing and increased urinary frequency. The objective of the present study was to evaluate the effects of topical pilocarpine solutions as mouthwashes on salivary flow and their adverse effects on healthy subjects. Forty volunteers received 10 ml 0.5, 1 and 2% pilocarpine solutions or 0.9% saline in a randomized, double-blind, placebo-controlled manner. Salivation was measured before and 45, 60 and 75 min after mouth rinsing for 1 min with 10 ml of saline or pilocarpine solutions. Vital signs were measured and ocular, gastrointestinal and cardiovascular symptoms, anxiety and flushing were estimated using visual analog scales. There was a dose-dependent increase in salivation. Salivation measured after 1 and 2% pilocarpine (1.4 ± 0.36 and 2.22 ± 0.42 g, respectively) was significantly (P<0.001) higher than before (0.70 ± 0.15 and 0.64 ± 0.1 g), with a plateau between 45 and 75 min. Cardiovascular, visual, gastrointestinal and behavioral symptoms and signs were not changed by topical pilocarpine. Mouth rinsing with pilocarpine solutions at concentrations of 1 to 2% induced a significant objective and subjective dose-dependent increase in salivary flow, similar to the results reported by others studying the effect of oral 5 mg pilocarpine. The present study revealed the efficacy of pilocarpine mouthwash solutions in increasing salivary flow in healthy volunteers, with no adverse effects. Additional studies on patients with xerostomia are needed.info:eu-repo/semantics/openAccessAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research v.35 n.1 20022002-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2002000100015en10.1590/S0100-879X2002000100015
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Bernardi,R.
Perin,C.
Becker,F.L.
Ramos,G.Z.
Gheno,G.Z.
Lopes,L.R.
Pires,M.
Barros,H.M.T.
spellingShingle Bernardi,R.
Perin,C.
Becker,F.L.
Ramos,G.Z.
Gheno,G.Z.
Lopes,L.R.
Pires,M.
Barros,H.M.T.
Effect of pilocarpine mouthwash on salivary flow
author_facet Bernardi,R.
Perin,C.
Becker,F.L.
Ramos,G.Z.
Gheno,G.Z.
Lopes,L.R.
Pires,M.
Barros,H.M.T.
author_sort Bernardi,R.
title Effect of pilocarpine mouthwash on salivary flow
title_short Effect of pilocarpine mouthwash on salivary flow
title_full Effect of pilocarpine mouthwash on salivary flow
title_fullStr Effect of pilocarpine mouthwash on salivary flow
title_full_unstemmed Effect of pilocarpine mouthwash on salivary flow
title_sort effect of pilocarpine mouthwash on salivary flow
description Pilocarpine is a cholinergic agonist that increases salivary flow and has been used to treat xerostomia. Oral intake is the most frequent route of administration. Adverse effects are dose-dependent and include sudoresis, facial blushing and increased urinary frequency. The objective of the present study was to evaluate the effects of topical pilocarpine solutions as mouthwashes on salivary flow and their adverse effects on healthy subjects. Forty volunteers received 10 ml 0.5, 1 and 2% pilocarpine solutions or 0.9% saline in a randomized, double-blind, placebo-controlled manner. Salivation was measured before and 45, 60 and 75 min after mouth rinsing for 1 min with 10 ml of saline or pilocarpine solutions. Vital signs were measured and ocular, gastrointestinal and cardiovascular symptoms, anxiety and flushing were estimated using visual analog scales. There was a dose-dependent increase in salivation. Salivation measured after 1 and 2% pilocarpine (1.4 ± 0.36 and 2.22 ± 0.42 g, respectively) was significantly (P<0.001) higher than before (0.70 ± 0.15 and 0.64 ± 0.1 g), with a plateau between 45 and 75 min. Cardiovascular, visual, gastrointestinal and behavioral symptoms and signs were not changed by topical pilocarpine. Mouth rinsing with pilocarpine solutions at concentrations of 1 to 2% induced a significant objective and subjective dose-dependent increase in salivary flow, similar to the results reported by others studying the effect of oral 5 mg pilocarpine. The present study revealed the efficacy of pilocarpine mouthwash solutions in increasing salivary flow in healthy volunteers, with no adverse effects. Additional studies on patients with xerostomia are needed.
publisher Associação Brasileira de Divulgação Científica
publishDate 2002
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2002000100015
work_keys_str_mv AT bernardir effectofpilocarpinemouthwashonsalivaryflow
AT perinc effectofpilocarpinemouthwashonsalivaryflow
AT beckerfl effectofpilocarpinemouthwashonsalivaryflow
AT ramosgz effectofpilocarpinemouthwashonsalivaryflow
AT ghenogz effectofpilocarpinemouthwashonsalivaryflow
AT lopeslr effectofpilocarpinemouthwashonsalivaryflow
AT piresm effectofpilocarpinemouthwashonsalivaryflow
AT barroshmt effectofpilocarpinemouthwashonsalivaryflow
_version_ 1756391012580720640